Search - tctmd.com

Displaying 201 - 220 of 1261

Sort: Relevancy | Date

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

News Daily News

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

September 20, 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

News Conference News ESC 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

September 02, 2019

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

News Conference News ESC 2019

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Yael L. Maxwell

September 01, 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

News Conference News ESC 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Michael O'Riordan

September 01, 2019

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

News Daily News

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

August 15, 2019

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

News Daily News

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

Yael L. Maxwell

August 15, 2019

In Carotid RCTs, Outcomes Improved Over Time for CEA but not CAS: Meta-analysis

News Daily News

In Carotid RCTs, Outcomes Improved Over Time for CEA but not CAS: Meta-analysis

August 09, 2019

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

News Daily News

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

Yael L. Maxwell

August 08, 2019

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

News Daily News

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

July 11, 2019

News Daily News

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

July 04, 2019

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

News Daily News

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

June 17, 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

June 13, 2019

Potential Warning Signs Seen for NOAC Use After TAVR

News Daily News

Potential Warning Signs Seen for NOAC Use After TAVR

June 12, 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

June 06, 2019

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

News Conference News SCAI 2019

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Yael L. Maxwell

June 04, 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

News Conference News EuroPCR 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

May 22, 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

May 16, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

News Daily News

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

May 10, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.